Registered entities
Nantkwest, Inc.
Reg. No. 431979754United States
Conkwest, Inc.
Reg. No. 1326110United States
Investor mix
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Other / undisclosed | 1 | 17% |
Developer of immunotherapy to treat cancer, infectious, and inflammatory diseases
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Other / undisclosed | 1 | 17% |